The bromobenzene market has been growing rapidly over the years with increasing applications of bromobenzene in flame retardants, rubber accelerators, pesticides, and others. Bromobenzene is an organobromine compound that is aromatic in nature. It is a colorless odorless dense liquid. Bromobenzene has excellent chemical properties such as flame retardancy, high flash point, and stability. It is commonly used in flame retardants for plastics, textiles, rubber and other materials. With rising demand for flame retardant materials from various end-use industries such as construction, automotive, electrical & electronics, the demand for bromobenzene is expected to rise significantly over the coming years. The Global Bromobenzene Market Size is estimated to be valued at US$ 77.7 Bn in 2024 and is expected to exhibit a CAGR of 20% over the forecast period 2024 to 2030.
Key Takeaways
Key players operating in the bromobenzene market are Activision Blizzard, Inc., NVIDIA Corporation, Valve Corporation, Nintendo of America Inc., Riot Games, Inc., Epic Games, Inc., Tencent Holding Limited, Gameloft SE, Turner Broadcasting System, CJ Corporation and Electronic Arts Inc. and Others. There is an increasing demand for bromobenzene from flame retardant applications owing to stringent government regulations regarding fire safety standards in buildings and vehicles. The demand for bromobenzene from rubber accelerators and intermediates is also growing at a substantial rate.
Technological advancements in bromobenzene production processes have made them more efficient and cost-effective. Bromobenzene manufacturers are investing in R&D to develop innovative bromobenzene products with better properties and performance. This is expected to open new growth avenues for the bromobenzene market.
Market Trends
Increasing demand from the construction industry: The rising construction activities around the world especially in developing economies has augmented the demand for flame retardant materials which in turn has propelled the consumption of bromobenzene in recent years.
Growing use in automotive interiors: With increasing focus on passenger safety, bromobenzene is widely used as a flame retardant in automotive interiors, engines, and other components. This is expected to drive its demand over the forecast period.
Market Opportunities
Focus on development of bio-based and eco-friendly bromobenzene: Stringent environmental regulations regarding emission and usage of toxic substances provide opportunities for manufacturers to develop bio-based and non-toxic bromobenzene through innovative technologies.
Emerging applications in lithium-ion batteries: With the increasing adoption of electric vehicles and energy storage devices, the demand for lithium-ion batteries is growing exponentially which can boost the usage of bromobenzene as an electrolyte solvent in the coming years.
Impact of COVID-19 on Bromobenzene Market Growth
The outbreak of COVID-19 pandemic had a major impact on the bromobenzene market growth. The strict lockdowns imposed by various governments globally led to temporary closure of manufacturing units disrupting the supply chain network. This negatively affected the production volumes of bromobenzene during the initial months of 2020. However, with easing of restrictions from mid-2020, the manufacturing activities have resumed with adoption of proper safety measures. But travel restrictions and halted construction projects impacted the demand from end use industries like construction and automotive sector.
Post pandemic, the bromobenzene market is projected to witness steady recovery in coming years due to rising infrastructure development and rebound in automotive industry. The demand from agrochemicals sector is also expected to increase with growing focus on agricultural production. The major players operating in the market are undertaking strategic initiatives like capacity expansions, long term contracts and forward integration to boost supply chain resilience. The rising investments in renewable energy projects involving use of bromobenzene as flame retardant will further aid the market growth. Significant research in pharmaceutical applications is also anticipated to open new avenues during the forecast period.
Geographical Regions with Highest Bromobenzene Market Value
Asia Pacific region accounted for the largest share of global bromobenzene market in terms of value during pre-pandemic years owing to presence of major export oriented manufacturing units in countries like China and India. The increasing use of bromobenzene as an intermediate in agrochemicals and flame retardants production contributed to market dominance of this region. Going forward, countries like Vietnam, Indonesia and Thailand are projected to witness strong growth supported by shifting of production bases and rising investments in infrastructure sector in these emerging economies.
Fastest Growing Regional Market for Bromobenzene
Europe region is identified as the fastest growing regional market for bromobenzene over the forecast period. This can be attributed to robust policies encouraging sustainable construction and stringent norms regarding flame retardant applications in automotive and electrical industries. Furthermore, presence of leading automobile OEMs and adoption of electric vehicles in countries like Germany, France, UK and Italy will spur the demand for bromobenzene containing specialty polymers and chemical intermediates. The increasing R&D efforts directed towards life sciences applications is also expected to boost the consumption of bromobenzene significantly across European markets.
Get More Insights on This Topic: https://www.pressreleasebulletin.com/bromobenzene-market-size-share-and-growth-forecast-2024-2030/
Non-Small Cell Lung Cancer Market is Expected to Increase With a CAGR of 10.7% for the Study Period of 2017-2030: DelveInsight (Albany, US) DelveInsight has introduced a new Market Insights, Epidemiology, and Market Forecast Report on "Non-Small Cell Lung Cancer Market Insights, Epidemiology, and Market Forecast-2030" to its portfolio.Key Highlights from report are:As per the DelveInsight analysis, the total incident cases of NSCLC in the 7MM were observed to be 484,726 cases in the year 2017.
These cases are expected to grow with a significant CAGR in the study period 2017–2030.There are different types of treatment available for NSCLC; however, mainly 10 types of standard treatment are used, which include Surgery, Radiation therapy, Chemotherapy, Targeted therapy, Immunotherapy, Laser therapy, Photodynamic therapy (PDT), Cryosurgery, Electrocautery, and Watchful waiting.The market size of NSCLC in the 7MM is expected to increase during study period.
According to the estimates, the highest contribution in the market size of NSCLC is from the United States followed by Japan, Germany, and the UK.One of the most exciting developments in lung cancer medicine is the introduction of targeted treatments.Request for free sample pages to know more on Non-Small Cell Lung Cancer Market Forecast NSCLC is the most common type of lung cancer accounted for approximately 85% of all lung cancers.
The disease epidemiology included in the report provides historical as well as forecasted Non-Small Cell Lung Cancer epidemiology, which is segmented as Total Incident cases of NSCLC patients, Total Incident cases of NSCLC patients by Histology, Total Diagnosed cases of NSCLC patients by Stages, Total NSCLC cases of patients by Genetic mutation/Biomarkers, and Total Treated Cases of NSCLC patients by Line of Therapies scenario of NSCLC in the 7MM.The total NSCLC incident cases in the 7MM were observed to be 484,726 cases in 2017.Click here to know more on Non-Small Cell Lung Cancer pipelineNSCLC report encloses the detailed analysis of Non-Small Cell Lung Cancer marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs.
The therapies that are approved for the NSCLC treatment are Rozlytrek (Entrectinib), Imfinzi (Durvalumab), Opdivo (Nivolumab), Tecentriq (Atezolizumab), Keytruda (Pembrolizumab), Tafinlar (Dabrafenib) in combination with Mekinist (Trametinib), Tagrisso (osimertinib), Lorbrena/Lorviqua (Lorlatinib), Vizimpro (Dacomitinib), Alunbrig (Brigatinib), Alecensa (Alectinib), Vitrakvi (Larotrectinib), Portrazza (Necitumumab) along with many more.Drugs covered in the report are:-There are several key players robustly involved in developing potential products such asNazartinib (EGF816)Capmatinib (INC280)Tepmetko (tepotinib)MerestinibJNJ-61186372 (JNJ-6372)Vemurafenib Plus CobimetinibX-396 (Ensartinib)Tedopi (OSE2101)Selpercatinib (LY3527723/ LOXO-292)SAR408701Braftovi (encorafinib) + Mektovi (binimetinib)PADCEV (enfortumab vedotin/ASG-22ME)Pralsetinib (BLU-667)TAK-788: Canakinumab (ACZ885)Avelumab (Bavencio)Veliparib (ABT-888): Sitravatinib (MGCD516)TesevatinibRomiplostim: CabozantinibSym015AMG 510INCMGA00012 (MGA012)Libtayo (Cemiplimab)BavituximabM7824 (Bintrafusp alfa)And many others Key Players covered in the report are:-Novartis PharmaceuticalsMerck KGaAEli Lilly and CompanyJanssen Research & DevelopmentHoffmann-La RocheXcoveryBeyondSpring PharmaceuticalsOSE ImmunotherapeuticsSanofiPfizerAstellas PharmaSeattle GeneticsBlueprint Medicines CorporationTakedaAbbVieKadmon CorporationAmgenSymphogenRegeneron PharmaceuticalsPeregrine PharmaceuticalsAvid BioservicesGlaxoSmithKlineAnd many othersThe report includes provides in depth analysis historical and forecasted Market Share (%) Distribution of NSCLC, Market Share (%) Distribution of NSCLC by Mutations/Biomarkers, Total Market Size of PD-L1 NSCLC, Total Market Size of BRAF NSCLC, Total Market Size of c-Met, Total Market Size of EGFR, Total Market Size of ALK as well.The reasons for buying this report:The report proffers an overview of pathophysiology, various diagnostic approaches and NSCLC treatment algorithm, including detailed chapters for marketed products and emerging therapies.Historical and forecasted Non-Small Cell Lung Cancer epidemiology in 7MM covering the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2017-2030.Detailed historical and forecasted NSCLC market covering the United States, EU5 and Japan from 2017-2030.
Pipeline analysis across different stages of development (Phase III and Phase II), different emerging trends and comparative analysis of pipeline products with comprehensive clinical profiles, key cross-competition, launch date along with product development activities.
The Spirulina Market is expected to grow at a CAGR of 10.3% from 2020-2030, according to a new research report by Next Move Strategy ConsultingSpirulina is a blue green algae with high nutrient content, usually consumed by human & animals.
It is also used as a complementary diet ingredient in aquaculture & poultry feeds owing to the presence of high protein & vitamin content.According to the report, growth in health consciousness among people and the rising demand for dietary supplements are major factors driving the spirulina market growth.
Additionally, high penetration of spirulina in industries such as cosmetics and pharmaceutical owing to the advantageous properties such as anti-aging, anti-wrinkles and othersare bringing changes in market tends.However, low stability & poor sustainability of spirulina derived colours is expected to restrict the market growth.Moreover, growth in research & development activities followed by untapped market opportunities in developing economies are anticipated to provide numerous opportunities to the market players in the coming few years.On the basis of type, spirulina market share is segmented into Arthrospira Platensis and Arthrospira Maxima.
Arthrospira Maxima dominates the global Spirulina market and will be the dominant throughout the forecasted period.On the basis of application, the Spirulina market is categorised into Nutraceuticals, Food & Beverages, Cosmetics, Animal Feed, and Others.Food & Beverages segment is likely to develop significantly over the period of time owing to fast growing food & beverage industry.On the basis of drug formulation, the spirulina market is bifurcated into Powder, Tablet & Capsule, Liquid, and Granule & Gelling Agent.
Powder segment is expected to account for the major market share & dominate the market growth over the forecast period.North America dominates the spirulina market in terms of market size over the forecast period, owing to rising health consciousness among people.
Hansen Holding A/S, Algenol Biofuels Inc., Dongtai City Spirulina Bio-engineering Co., Ltd., Prolgae, Parry Neutraceuticals, Sensient Technologies Corporation, DDW Inc., Algatec and Naturex S.A.Browse key industry insights from the report, “Spirulina Market Size By Type (ArthrospiraPlatensis and Arthrospira Maxima) By Application (Nutraceuticals, Food & Beverages, Cosmetics, Animal Feed, and Others), By Drug Formulation (Powder, Tablet & Capsule, Liquid, and Granule & Gelling Agent)Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, Russia, China, India, Japan, Australia, Indonesia, Malaysia, South Korea, Brazil, Mexico, South Africa, Saudi Arabia, UAE, Kuwait), Growth Potential, Price Trends, Competitive Market Share & Forecast, 2020–2030” in detail along with the table of contents:Key Insights from the Spirulina Market Report:Asia Pacific is the fastest growing region in Spirulina market owing to the rising demand of spirulina from various industries such as cosmetics, food , healthcare and others and government initiatives to promote local spirulina production.The Food & Beverages segment dominates the market in terms of application and is expected to grow at a significant CAGR to maintain the lead till 2030.Some of the major players in the market are DIC Corporation, Cyanotech Corporation, Chr.
This report studies the global market size of Robotic Surgery Systems in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Robotic Surgery Systems in these regions.
This report also studies the global Robotic Surgery Systems market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
Market size by End User
Rest of Central & South America
The study objectives of this report are:
To study and analyze the global Robotic Surgery Systems market size (value & volume) by company, key regions, products and end user, breakdown data from 2013 to 2017, and forecast to 2025.
Latest Research Report on “Sports Medicine Products Market” Added by Analytical Research Cognizance which covers Market Overview, Future Economic Impact, Competition by Manufacturers, Supply (Production), & Consumption Analysis
This report studies the global market size of Sports Medicine Products Market in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Sports Medicine Products in these regions.
This report also studies the global Sports Medicine Products market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
Get Sample for Sports Medicine Products Market Report @ http://www.arcognizance.com/enquiry-sample/131077
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Market size by End User
